Biogen

Biotech & Life Sciences · Cambridge, United States · Founded 1978 · IPO 1991

Innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases MoreLess

Biogen is a global biotechnology company that has a particular focus on neuroscience. The company specializes in the discovery, development, and delivery of therapies for neurological disorders, such as multiple sclerosis and other complex and devastating diseases.

Founded in 1978, the company has a long history in the biotechnology industry. Its business model is centered on research and development, which leads to the commercialization of new drugs. This, in turn, generates value for shareholders and the communities it serves.

Keywords: biotechnology, neuroscience, neurological disorders, multiple sclerosis, therapies, drug development, innovative science, neurodegenerative diseases, pharmaceuticals, life sciences

Valuation $37B

Revenue $10B

EBITDA $2.79B

Talent graph

Biogen's talent

Book a demo to see the people

Team profiled 477 named & role-tagged

Founders /100 quality score

Key operators 3 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

3 investors on Biogen's cap table

Sourced from Dealroom's funding history.

Series B+ 3 investors entered at this stage

Asset Management Ventures

Kleiner Perkins

Venrock

Global footprint

Where Biogen has talent and traffic

Workforce by country

🇺🇸 United States · Cambridge HQ

Book a demo for the full country breakdown

Market sentiment

What the market is saying about Biogen

An AI-synthesized read of the highest-engagement posts about Biogen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Biogen on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles